MORE THAN SCLERODERMA Trademark

Trademark Overview


On Friday, February 2, 2018, a trademark application was filed for MORE THAN SCLERODERMA with the United States Patent and Trademark Office. The USPTO has given the MORE THAN SCLERODERMA trademark a serial number of 87782084. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, July 13, 2024. This trademark is owned by Boehringer Ingelheim Pharmaceuticals, Inc.. The MORE THAN SCLERODERMA trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Promoting awareness of scleroderma, its symptoms, detection, prevention and treatment

Providing information on scleroderma, its symptoms, detection, prevention and treatment, including medical information on patients living with the disease
more than scleroderma

General Information


Serial Number87782084
Word MarkMORE THAN SCLERODERMA
Filing DateFriday, February 2, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, July 13, 2024
Registration Number5603300
Registration DateTuesday, November 6, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 10, 2018

Trademark Statements


Description of MarkThe mark consists of a blue, circular solid carrying a "greater than" mathematical symbol depicted in white, to the left of the wording "More than Scleroderma", with "More than" depicted on one line in dark blue and "Scleroderma" in light blue on the line below, and with such wording situated above a red horizontal, solid line extending the length of the term "Scleroderma".
Indication of Colors claimedThe color(s) blue, light blue, white and red is/are claimed as a feature of the mark.
Goods and ServicesPromoting awareness of scleroderma, its symptoms, detection, prevention and treatment
Goods and ServicesProviding information on scleroderma, its symptoms, detection, prevention and treatment, including medical information on patients living with the disease
NOT AVAILABLE"SCLERODERMA"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, February 12, 2018
Primary Code035
First Use Anywhere DateFriday, February 16, 2018
First Use In Commerce DateFriday, February 16, 2018

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 12, 2018
Primary Code044
First Use Anywhere DateFriday, February 16, 2018
First Use In Commerce DateFriday, February 16, 2018

Trademark Owner History


Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Trademark Events


Event DateEvent Description
Monday, February 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 6, 2018NEW APPLICATION ENTERED
Wednesday, May 16, 2018ASSIGNED TO EXAMINER
Tuesday, July 10, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 13, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 18, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, May 18, 2018EXAMINERS AMENDMENT E-MAILED
Friday, May 18, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 18, 2018EXAMINER'S AMENDMENT ENTERED
Friday, May 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 6, 2018ASSIGNED TO LIE
Wednesday, June 20, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 4, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 5, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, September 5, 2018USE AMENDMENT FILED
Thursday, September 27, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 28, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, October 1, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 2, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 6, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, January 2, 2024TEAS SECTION 8 & 15 RECEIVED
Saturday, July 13, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, July 13, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, July 13, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED